🎉 M&A multiples are live!
Check it out!

MoonLake Valuation Multiples

Discover revenue and EBITDA valuation multiples for MoonLake and similar public comparables like Vivoryon Therapeutics, Pharming, and Julphar.

MoonLake Overview

About MoonLake

MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients.


Founded

2020

HQ

United States of America
Employees

100

Website

moonlaketx.com

Financials

LTM Revenue n/a

LTM EBITDA -$161M

EV

$1.8B

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

MoonLake Financials

MoonLake has a last 12-month revenue of n/a and a last 12-month EBITDA of -$161M.

In the most recent fiscal year, MoonLake achieved revenue of n/a and an EBITDA of -$142M.

MoonLake expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See MoonLake valuation multiples based on analyst estimates

MoonLake P&L

FY 2023 FY 2024 FY 2025 LTM NTM
Revenue n/a n/a XXX XXX XXX
Gross Profit n/a n/a XXX XXX XXX
Gross Margin NaN% NaN% XXX XXX XXX
EBITDA -$54.1M -$142M XXX XXX XXX
EBITDA Margin -Infinity% -Infinity% XXX XXX XXX
Net Profit -$50.0M -$36.0M XXX XXX XXX
Net Margin -Infinity% -Infinity% XXX XXX XXX
Net Debt n/a n/a XXX XXX XXX

Financial data powered by Morningstar, Inc.

MoonLake Stock Performance

As of April 15, 2025, MoonLake's stock price is $36.

MoonLake has current market cap of $2.3B, and EV of $1.8B.

See MoonLake trading valuation data

MoonLake Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$1.8B $2.3B XXX XXX XXX XXX $-2.22

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

MoonLake Valuation Multiples

As of April 15, 2025, MoonLake has market cap of $2.3B and EV of $1.8B.

MoonLake's trades at n/a LTM EV/Revenue multiple, and -11.3x LTM EBITDA.

Analysts estimate MoonLake's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for MoonLake and 10K+ public comps

MoonLake Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV $1.8B XXX XXX XXX
EV/Revenue n/a XXX XXX XXX
EV/EBITDA -12.8x XXX XXX XXX
P/E -19.0x XXX XXX XXX
P/E/Growth n/a XXX XXX XXX
EV/FCF -15.5x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get MoonLake Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

MoonLake Valuation Multiples

MoonLake's NTM/LTM revenue growth is n/a

MoonLake's revenue per employee for the last fiscal year averaged n/a, while opex per employee averaged $1.4M for the same period.

Over next 12 months, MoonLake's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate MoonLake's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for MoonLake and other 10K+ public comps

MoonLake Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth n/a XXX XXX XXX XXX
EBITDA Margin n/a XXX XXX XXX XXX
EBITDA Growth 162% XXX XXX XXX XXX
Rule of 40 (SaaS-only) n/a XXX XXX XXX XXX
Revenue per Employee n/a XXX XXX XXX XXX
Opex per Employee $1.4M XXX XXX XXX XXX
S&M Expenses to Revenue n/a XXX XXX XXX XXX
G&A Expenses to Revenue n/a XXX XXX XXX XXX
R&D Expenses to Revenue n/a XXX XXX XXX XXX
Opex to Revenue n/a XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

MoonLake Public Comps

See public comps and valuation multiples for Drug Development & Therapeutics comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Julphar XXX XXX XXX XXX XXX XXX
Benevolent AI XXX XXX XXX XXX XXX XXX
Galapagos XXX XXX XXX XXX XXX XXX
Pharming XXX XXX XXX XXX XXX XXX
Vivoryon Therapeutics XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

MoonLake M&A and Investment Activity

MoonLake acquired  XXX companies to date.

Last acquisition by MoonLake was  XXXXXXXX, XXXXX XXXXX XXXXXX . MoonLake acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by MoonLake

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About MoonLake

When was MoonLake founded? MoonLake was founded in 2020.
Where is MoonLake headquartered? MoonLake is headquartered in United States of America.
How many employees does MoonLake have? As of today, MoonLake has 100 employees.
Who is the CEO of MoonLake? MoonLake's CEO is Dr. Jorge Santos da Silva.
Is MoonLake publicy listed? Yes, MoonLake is a public company listed on NAS.
What is the stock symbol of MoonLake? MoonLake trades under MLTX ticker.
When did MoonLake go public? MoonLake went public in 2022.
Who are competitors of MoonLake? Similar companies to MoonLake include e.g. Julphar, Benevolent AI, Galapagos, Pharming.
What is the current market cap of MoonLake? MoonLake's current market cap is $2.3B
What is the current EBITDA of MoonLake? MoonLake's last 12-month EBITDA is -$161M.
What is the current EV/EBITDA multiple of MoonLake? Current EBITDA multiple of MoonLake is -11.3x.
Is MoonLake profitable? Yes, MoonLake is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.